Cardiorespiratory fitness — most precisely measured as VO2max, the maximal rate of oxygen consumption during exhaustive exercise — has emerged as one of the cleanest single biomarkers in longevity medicine. The dose-response with all-cause mortality is steep and well-replicated: the lowest fitness quintile carries roughly 4–5× the mortality risk of the highest quintile in long-follow-up cohort studies, with continuous benefit observed at higher fitness levels. The cognitive picture is parallel: low cardiorespiratory fitness in midlife predicts substantially elevated dementia risk decades later, with hazard ratios in the 0.5–0.7 range for the highest versus lowest fitness tiers in the Cooper Center and similar cohorts.
The mechanism is multi-pathway and substantially mediated by the same factors that drive cognitive risk. Higher cardiorespiratory fitness reflects better mitochondrial function, more efficient glucose handling, lower resting heart rate (autonomic balance), better vascular function, lower systemic inflammation, higher cerebral blood flow, and greater BDNF response to exercise stimulus. Each of these is independently associated with cognitive trajectory; VO2max integrates them into a single number that captures the cumulative effect of years of behavior on cardiovascular and metabolic systems. The patient who improves from the lowest quintile to the second-lowest quintile is making a clinically meaningful change in their cognitive trajectory.
VO2max can be estimated without a metabolic cart in most clinical settings. Direct measurement requires graded exercise testing with gas exchange analysis, which is uncommon outside cardiology or sports medicine. Useful estimation methods include the Cooper 12-minute run test (distance covered correlates with VO2max), the 1-mile walk test (time and post-exercise heart rate), the Rockport Fitness Walking Test, step tests, and submaximal cycle ergometer protocols. Wearables (Apple Watch, Garmin, Whoop, Fitbit) now estimate VO2max from heart-rate response during walking and running with reasonable accuracy at population level — useful for tracking trends, less precise for absolute values. The clinical estimate is better than no estimate; the trend over time is what matters most for clinical decision-making.
Age- and sex-adjusted targets translate VO2max into actionable categories. For a 60-year-old man, average VO2max is roughly 30 mL/kg/min; below 25 indicates the high-risk range associated with elevated dementia and mortality risk, while above 35 places the patient in the favorable range. For a 60-year-old woman, average is roughly 24 mL/kg/min, with the high-risk range below 20 and the favorable range above 28. These numbers shift with age (declining roughly 10% per decade in sedentary adults but substantially less in those who train), and the most actionable clinical message is not the absolute number but the trajectory and the patient's quintile position.
The clinical conversation translates the number into behavior. Patients in the bottom quintile have the highest leverage — small fitness improvements (moving from 25 to 28 in the example above) produce disproportionate mortality and cognitive risk reduction. The prescription that produces VO2max improvement is well-characterized: aerobic exercise above the talk-test threshold (zone 2 by heart rate; roughly RPE 5/10) for 150+ minutes weekly, supplemented by one or two higher-intensity interval sessions weekly to push the upper end of capacity. Resistance training contributes indirectly through preserved muscle mass and metabolic health. Progress is measurable within 8–12 weeks of consistent training in previously sedentary adults, and ongoing improvement continues for many months.
The discipline is to use measurement to drive behavior, not to add anxiety. Patients in higher-risk fitness categories benefit from knowing the number and the trajectory, with the clinical conversation framed around the largest single modifiable risk factor most clinicians never discuss with them. Patients in favorable ranges benefit from maintenance and from understanding that the trajectory is what matters, not the absolute number. The wearable that estimates VO2max becomes a clinical tool when the clinician treats it as one and asks about it at every visit.